Facebook Linkedin Tumblr Twitter
Sign in
  • My Account
  • orders
Sign in
Welcome!Log into your account
Forgot your password?
Password recovery
Recover your password
Search
  • Sign in / Join
Facebook Linkedin Tumblr Twitter
Sign in
Welcome! Log into your account
Forgot your password? Get help
Password recovery
Recover your password
A password will be e-mailed to you.
Market Exclusive #1 Financial News & Analysis Market Exclusive
Market Exclusive #1 Financial News & Analysis
  • My Account
  • orders
Home Biotech Stocks

Biotech Stocks

Random
  • Latest
  • Featured posts
  • Most popular
  • 7 days popular
  • By review score
  • Random
biotechnology

Here’s a Look at the Current CDK Inhibition Landscape

- February 11, 2016
biotech

Biotech Movers: Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) And Aldeyra Therapeutics, Inc. (NASDAQ:ALDX)

Ups And Downs In Biotech This Week: PTC Therapeutics, Inc. (NASDAQ:PTCT), Puma Biotechnology Inc (NYSE:PBYI) and Nektar Therapeutics (NASDAQ:NKTR)

valeant

A Tough Lesson Learnt: Valeant Pharmaceuticals Intl Inc (NYSE:VRX) and Endo International plc (NASDAQ:ENDP)

Alexion

Here’s Our Highlight From the Latest Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) Update

Regulus Therapeutics

Xanthopoulos Steps down, Trouble Brewing for Regulus?

ME Staff - June 3, 2015 0

Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) Unveils Successful AIM-TD Clinical Trial Results

Andy Parker - September 23, 2016 0

GlaxoSmithKline plc. (ADR)(NYSE:GSK) Inks $43 Million Artificial Intelligence Deal To Develop...

- July 5, 2017 0

Phase I Trial For Galapagos NV (ADR) (NASDAQ:GLPG) GLPG3067 For Cystis...

- March 23, 2017 0

Here’s What’s Moving Exelixis, Inc. (NASDAQ:EXEL) Right Now

- October 17, 2017 0
Allergan Plc

Allergan Plc (NYSE:AGN) Launches Campaign To Fight Preventable Blindness In America

Andy Parker - February 8, 2017 0
Pfizer Inc (NYSE:PFE)

Pfizer Inc. (NYSE:PFE) Wants You To “Get Old”

Andy Parker - June 28, 2016 0
Johnson & Johnson

Johnson & Johnson (NYSE:JNJ) Gets $17 Million From NYC For JLABS...

Andy Parker - January 11, 2017 0
AbbVie Inc

Here’s What The AbbVie and Voyager Therapeutics Deal Really Means

- February 21, 2018 0
GBT

All You Need To Know About Global Blood Therapeutics Inc’s (NASDAQ:GBT)...

Jennifer Aldershot - May 16, 2016 0
123...146Page 1 of 146

Latest Articles

  • Weekly Roundup on the Cannabis Sector & Psychedelic Sector
  • Weekly Roundup on the Cannabis Sector & Psychedelic Sector
  • Weekly Roundup on the Cannabis Sector & Psychedelic Sector

EDITOR PICKS

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

April 13, 2026

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

April 6, 2026

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

March 29, 2026

POPULAR POSTS

Weekly Biotech Report covering – Opko Health Inc (NYSE:OPK) Intercept...

April 11, 2016

Facebook Inc – (NASDAQ:FB) Might Be Moving Away From Its...

April 8, 2016
biotechnology

Biotechnology Movers: Here’s Why Citius Pharmaceuticals Inc (NASDAQ:CTXR) Is Running Right...

November 8, 2017

POPULAR CATEGORY

  • SEC Filings97015
  • Analyst Ratings21747
  • Insider Trading7769
  • Earnings4727
  • LSE4165
  • dividend announcements2433
  • Tech News1583
  • Stocks1511
  • Stock Market News1478
Market Exclusive #1 Financial News & Analysis
ABOUT US
Market Exclusive offers the latest financial news and analysis for selected US stocks and securities. We are an investor driven research platform where new investment ideas from a exclusively selected group of seasoned investment analysts and qualified members from various disciplines are able to deliver their investment thesis’ across various industries and sectors. Our burgeoning team is comprised of individuals with strong backgrounds from various disciplines and businesses. Our goal is to provide an exclusive forum for contributors and users to leverage the knowledge base in order to make smarter investing decisions. At Market Exclusive, we believe that quality information from experienced well seasoned contributors provide our members with an edge that allows them to make wise investment choices. Market Exclusive is not a registered investment broker/dealer. The content on this site is for informational purposes only. Additionally, the content on this site does not represent the views of Market Exclusive and is solely a representation of the authors who publish them. Before investing in any security you should do your own due diligence and consult with a registered broker or financial advisor.
Contact us: [email protected]
FOLLOW US
Facebook Linkedin Tumblr Twitter
  • SEC Filings
  • Stocks
  • Stock Market News
  • Tech News
  • Biotech Stocks
  • Featured
  • Small Caps
  • gold
  • Other News
  • Oil
  • Become a Contributor!
  • Advertise On Market Exclusive
  • Contact Us
© Market Exclusive 2019